Stay updated with breaking news from Fully Enrolled. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024 SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals TCON,…
CAHmelia Program in Adult Classic Congenital Adrenal Hyperplasia Achieves 50% Enrollment in CAHmelia-204 and Approaches 75% Enrollment in CAHmelia-203 Enrollment in P.O.W.E.R. Study for Polycystic... | May 15, 2023
Results from the first session of Late-Breaking Clinical Trials were presented on Oct. 31 during The VEINS conference, hosted in Las Vegas, NV, announced by the VIVA Foundation.
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
LAS VEGAS, Oct. 31, 2022 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine ...